James A. Milligan

3.7k total citations · 1 hit paper
24 papers, 2.3k citations indexed

About

James A. Milligan is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, James A. Milligan has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in James A. Milligan's work include Sphingolipid Metabolism and Signaling (14 papers), Lipid Membrane Structure and Behavior (9 papers) and Carbohydrate Chemistry and Synthesis (5 papers). James A. Milligan is often cited by papers focused on Sphingolipid Metabolism and Signaling (14 papers), Lipid Membrane Structure and Behavior (9 papers) and Carbohydrate Chemistry and Synthesis (5 papers). James A. Milligan collaborates with scholars based in United States and United Kingdom. James A. Milligan's co-authors include Suzanne Mandala, Mark Rosenbach, James D. Bergstrom, Gan-Ju Shei, Rosemary Thornton, Richard Hajdu, Jeffrey J. Hale, Deborah Card, Hugh Rosen and Christopher L. Lynch and has published in prestigious journals such as Science, Journal of Biological Chemistry and Gut.

In The Last Decade

James A. Milligan

24 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

2002 1.4k citations Suzanne Mandala, Richard Hajdu et al. profile →

Peers

James A. Milligan

IMMUN

Rosemary Thornton United States

Mark Rosenbach United States

Richard B. Gilbertsen United States

Hidesuke Fukazawa Japan

Jean‐Bernard Denault Canada

Bruce A. Posner United States

Kristin Beebe United States

William F. Heath United States

Liguo New United States

G P Livi United States

Rosemary Thornton United States

James A. Milligan

2.0k ×1.2

477 ×1.0

IMMUN

314 ×0.8

569 ×1.8

89 ×0.5

Citations per year, relative to James A. Milligan James A. Milligan (= 1×) peers Rosemary Thornton

Countries citing papers authored by James A. Milligan

Since Specialization

Citations

This map shows the geographic impact of James A. Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Milligan more than expected).

Fields of papers citing papers by James A. Milligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Milligan. The network helps show where James A. Milligan may publish in the future.

Co-authorship network of co-authors of James A. Milligan

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Milligan. A scholar is included among the top collaborators of James A. Milligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Milligan. James A. Milligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agrawal, Sony, Richard Johnstone, David Pechter, et al.. (2015). Utilizing Low-Volume Aqueous Acoustic Transfer with the Echo 525 to Enable Miniaturization of qRT-PCR Assay. SLAS TECHNOLOGY. 21(1). 57–63. 12 indexed citations

Váchal, Petr, Jeffrey J. Hale, Lin Yan, et al.. (2006). Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorganic & Medicinal Chemistry Letters. 16(14). 3684–3687. 29 indexed citations

Yan, Lin, George Doherty, Jeffrey J. Hale, et al.. (2006). Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorganic & Medicinal Chemistry Letters. 16(14). 3679–3683. 15 indexed citations

Colandrea, Vincent J., Lin Yan, Jeffrey J. Hale, et al.. (2006). 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 2905–2908. 18 indexed citations

Yan, Lin, Richard J. Budhu, Christopher L. Lynch, et al.. (2006). 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3564–3568. 18 indexed citations

Yan, Lin, Jeffrey J. Hale, Sander G. Mills, et al.. (2006). SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 17(3). 828–831. 18 indexed citations

Hale, Jeffrey J., William Neway, Sander G. Mills, et al.. (2004). Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorganic & Medicinal Chemistry Letters. 14(12). 3351–3355. 64 indexed citations

Hale, Jeffrey J., Lin Yan, William Neway, et al.. (2004). Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720. Bioorganic & Medicinal Chemistry. 12(18). 4803–4807. 39 indexed citations

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3501–3505. 39 indexed citations

10.

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3495–3499. 26 indexed citations

11.

Yan, Lin, Jeffrey J. Hale, Christopher L. Lynch, et al.. (2004). Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4861–4866. 23 indexed citations

12.

Hale, Jeffrey J., Christopher L. Lynch, William Neway, et al.. (2004). A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists. Journal of Medicinal Chemistry. 47(27). 6662–6665. 65 indexed citations

13.

Candelore, Mari R., Michael Wright, Laurie Tota, et al.. (2002). Phytosphingosine 1-phosphate: a high affinity ligand for the S1P4/Edg-6 receptor. Biochemical and Biophysical Research Communications. 297(3). 600–606. 54 indexed citations

14.

Mandala, Suzanne, Rosemary Thornton, James A. Milligan, et al.. (1998). Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase. Journal of Biological Chemistry. 273(24). 14942–14949. 97 indexed citations

15.

Onishi, Janet C., James A. Milligan, Ángela Basilio, et al.. (1997). Antimicrobial Activity of Viridiofungins.. The Journal of Antibiotics. 50(4). 334–338. 32 indexed citations

16.

Mandala, Suzanne, Rosemary Thornton, Mark Rosenbach, et al.. (1997). Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis. Journal of Biological Chemistry. 272(51). 32709–32714. 113 indexed citations

17.

Kurtz, Martha, Cameron Douglas, J A Marrinan, et al.. (1994). Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrobial Agents and Chemotherapy. 38(12). 2750–2757. 60 indexed citations

18.

Dufresne, Claude, Kenneth E. Wilson, Deborah L. Zink, et al.. (1992). The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor.. Tetrahedron. 48(47). 10221–10226. 50 indexed citations

19.

Onishi, Janet C., George K. Abruzzo, Robert A. Fromtling, et al.. (1988). Mode of Action of β‐Lactone 1233A in Candida albicans. Annals of the New York Academy of Sciences. 544(1). 230–230. 1 indexed citations

20.

Onishi, Janet C., George K. Abruzzo, Robert A. Fromtling, et al.. (1988). Mode Of Action of L‐660,631 in Candida albicans. Annals of the New York Academy of Sciences. 544(1). 229–229. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact